# PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia

> **NCT03285503** · PHASE1 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 12 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole IM Depot

## Key facts

- **NCT ID:** NCT03285503
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-17
- **Primary completion:** 2019-10-14
- **Final completion:** 2019-10-14
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03285503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03285503, "PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03285503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*